BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23825680)

  • 1. Serum Heat Shock Protein 70 Concentration in Relation to Polycystic Ovary Syndrome in a Non-Obese Chinese Population.
    Gao H; Meng J; Xu M; Zhang S; Ghose B; Liu J; Yao P; Yan H; Wang D; Liu L
    PLoS One; 2013; 8(6):e67727. PubMed ID: 23825680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women.
    Gao H; Meng J; Xing H; Nie S; Xu M; Zhang S; Jin Y; Sun T; Huang H; Zhang H; Wang D; Liu L
    Hum Reprod; 2014 May; 29(5):1058-66. PubMed ID: 24585089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 5. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
    Can M; Duran C; Guney I; Elmas H; Ayhan M; Erdem SS
    Clin Investig Arterioscler; 2020; 32(6):256-262. PubMed ID: 32773256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and oxidative marker in women with PCOS.
    Bannigida DM; Nayak BS; Vijayaraghavan R
    Arch Physiol Biochem; 2020 May; 126(2):183-186. PubMed ID: 30450993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The abnormal level of HSP70 is related to Treg/Th17 imbalance in PCOS patients.
    Yang Y; Xia J; Yang Z; Wu G; Yang J
    J Ovarian Res; 2021 Nov; 14(1):155. PubMed ID: 34781996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.
    Samy N; Hashim M; Sayed M; Said M
    Dis Markers; 2009; 26(4):163-70. PubMed ID: 19729797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case-control study of women from Bahraini medical clinics.
    Kalyan S; Goshtesabi A; Sarray S; Joannou A; Almawi WY
    BMJ Open; 2018 Oct; 8(10):e021860. PubMed ID: 30368447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating neuregulin-1 levels in polycystic ovary syndrome.
    Arpacı H
    J Obstet Gynaecol; 2019 May; 39(4):504-509. PubMed ID: 30634887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome.
    Yilmaz MA; Duran C; Basaran M
    J Endocrinol Invest; 2016 Jan; 39(1):45-53. PubMed ID: 26100531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal expression of HSP70 may contribute to PCOS pathology.
    Wu G; Hu X; Ding J; Yang J
    J Ovarian Res; 2019 Aug; 12(1):74. PubMed ID: 31399035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.
    Souza Dos Santos AC; Soares NP; Costa EC; de Sá JC; Azevedo GD; Lemos TM
    Gynecol Endocrinol; 2015 Mar; 31(3):225-8. PubMed ID: 25373529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.
    Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W
    Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome.
    Gonzalez F; Thusu K; Abdel-Rahman E; Prabhala A; Tomani M; Dandona P
    Metabolism; 1999 Apr; 48(4):437-41. PubMed ID: 10206434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.